Drug-induced torsade de pointes: Pre-clinical and clinical studies for the prediction of a potential proarrhythmic adverse drug reaction;ETUDES ELECTROPHYSIOLOGIQUES PRE-CLINIQUES ET CLINIQUES EN VUE DE LA PREDICTION D'UN EFFET PROARYTHMIQUE (TORSADE DE POINTES) IATROGENE

Therapie

Volumn 52, Issue 4, 1997, Pages 271-280

  Jaillon, P ^a   Dupuis, B ^b   Dahan, R ^c   Bottineau, G ^d   Caron, J ^d   Cazor, J L ^d   Chauvenet, M ^d   Clement, J P ^d   Escande, D ^d   Faisandier, Y ^d   Funck Brentano, C ^d   Kolsky, H ^d   Koen, R ^d   Lacroix, D ^d   Leenhardt, A ^d   Lehner, J P ^d   Frost, J F ^d   Swynghedauw, B ^d   Vassort, G ^d   Weisscenburgcr, J ^d   Wohlhuter, C ^d   more..

^a HÔPITAL SAINT ANTOINE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Laboratoire Astra France   (France)

^d NONE

Author keywords

Proarrhythmic adverse drug reaction; QT finding; Torsades des pointes

Indexed keywords

AJMALINE; AMIODARONE; ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTIMITOTIC AGENT; APRINDINE; ATROPINE; CHLORAL HYDRATE; CIBENZOLINE; CLOFILIUM; DIPHEMANIL METHYLSULFATE; DISOPYRAMIDE; ENCAINIDE; ERYTHROMYCIN; FLECAINIDE; LORCAINIDE; PAMIDRONIC ACID; PROBUCOL; PROCAINAMIDE; PROPAFENONE; PROSTACYCLIN; QUINIDINE; SUXAMETHONIUM; TERODILINE; UNINDEXED DRUG; VASODILATOR AGENT; VINCAMINE;

ACTION POTENTIAL; CONFERENCE PAPER; DISEASE PREDISPOSITION; DOG; DRUG SCREENING; ELECTROCARDIOGRAM; GUINEA PIG; HEART ARRHYTHMIA; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PURKINJE CELL; QT INTERVAL; RABBIT; TORSADE DES POINTES; ANIMAL; ARTICLE; CELL MEMBRANE POTENTIAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; ELECTROCARDIOGRAPHY; IATROGENIC DISEASE; LONG QT SYNDROME; PATHOPHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; ELECTROCARDIOGRAPHY; GUINEA PIGS; HUMANS; IATROGENIC DISEASE; LONG QT SYNDROME; MEMBRANE POTENTIALS; RABBITS; TORSADES DE POINTES;

EID: 0031173748     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. + channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995; 92: 3381-3386.
2. kr. Implications for torsade de pointes and reverse use-dependence. Circulation 1996; 93: 407-411.
3. Lepeschkin E, Surawicz B. The measurement of the QT interval of the electrocardiogram. Circulation 1952; 6: 378-388.
4. Funck-Brentano C, Jaillon P. Rate-corrected QT interval: techniques and limitations. Am J Cardiol 1993; 72: 17B-22B.
5. Lecocq B, Lecocq V, Jaillon P. Physiologic relation between cardiac cycle and QT duration in healthy volunteers. Am J Cardiol 1989; 63: 481-486.
6. Sarma JSM, Sarma RJ, Bilitch M et al. An exponential formula for heart rate dependance of QT interval during exercise and cardiac pacing in humans, reevaluation of Bazett's formula. Am J Cardiol 1984; 54: 103-108.
7. Lecocq B, Lecocq V, Prost PL et al. Effects of bepridil and CERM 4205 (ORG, 30701) on the relation between cardiac cycle length and QT duration in healthy volunteers. Am J Cardiol 1990; 66 : 636-641.
8. Funck-Brentano C, Kibleur Y, Le Coz F et al. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans. Circulation 1991; 83: 536-545.
9. Démolis JL, Funck-Brentano C, Ropers J et al. Influence of dofetilide on QT-interval duration and dispersion at various heart rates during exercise in humans, Circulation 1996; 94: 1592-1599.
10. Funck-Brentano C. Rate dependance of class III actions in the heart. Fundam Clin Pharmacol 1993; 7: 51-59.
11. Thomas M, Maconochie JG, Fletcher E. The dilemma of the prolonged QT interval in early drug studies. Br J Clin Pharmacol 1996; 41: 77-81.
12. c interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization. Ann Epidemiol 1995; 5: 201-209.
13. Thompson D, Oster G. Use of terfenadine and contraindicated drugs. JAMA 1996; 275: 1339-1341.
14. Staffa JA, Jones JK, Gable CB et al. Risk of selected serious cardiax events among new users of antihistamines. Clin Ther 1995; 17 (6): 1062-1077.